{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:16:33Z","timestamp":1788174993638,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":154,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004919","name":"King Abdulaziz City for Science and Technology","doi-asserted-by":"publisher","award":["13-MED1765-20"],"award-info":[{"award-number":["13-MED1765-20"]}],"id":[{"id":"10.13039\/501100004919","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Hypophosphataemic rickets (HR) is a group of rare hereditary renal phosphate wasting disorders caused by mutations in the\n                      <jats:italic>PHEX<\/jats:italic>\n                      ,\n                      <jats:italic>FGF23<\/jats:italic>\n                      ,\n                      <jats:italic>DMP1<\/jats:italic>\n                      ,\n                      <jats:italic>ENPP1<\/jats:italic>\n                      ,\n                      <jats:italic>CLCN5<\/jats:italic>\n                      , SGK3,\n                      <jats:italic>SLC9A3R1<\/jats:italic>\n                      ,\n                      <jats:italic>SLC34A1<\/jats:italic>\n                      or\n                      <jats:italic>SLC34A3<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To identify the genetic defects in a patient with late-onset hypophosphatemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects<\/jats:title>\n                    <jats:p>A 15-year old boy with hypophosphatemic rickets, his unaffected parents and 7 siblings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Patients and their family members were initially analyzed for PHEX and FGF23 mutations by PCR-sequencing analysis. Exome and whole-genome sequencing were subsequently performed to identify causative genetic defects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The patient was normal until the age of 11 years old. He presented with severe rickets, hypophosphatemia with increased renal phosphate wasting, normal serum calcium, 1,25(OH)2D and parathyroid hormone (PTH), and mild elevation of serum FGF23. No mutation was detected in the genes known to cause HR such as PHEX, FGF23, DMP1, ENPP1, CLCN5, SGK3, FAM20C, SLC9A3R1, SLC34A1 or SLC34A3 by exome sequencing. A heterozygous variant c.448 C&gt;T (p.Arg150Cys) in the PTH1R gene was found in the patient, his unaffected father and 5 siblings. The same heterozygous variant was previously reported in human enchondromatosis and caused enchondroma-like lesions in transgenic mice. A large heterozygous deletion of more than 7 Kb in the SGK3 distal promoter was identified in the patient by whole genome sequencing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>SGK3 distal promoter deletion is likely the candidate gene causing the disease. PTH1R Arg150Cys variant may contribute to the disease phenotype. SGK3 promoter deletion should be considered in patients with late-onset genetic hypophosphatemic rickets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04335-0","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T10:46:55Z","timestamp":1774867615000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SGK3 promoter deletion in late-onset hypophosphatemic rickets, a possible genetic cause of the disease"],"prefix":"10.1186","volume":"21","author":[{"given":"Ahmet","family":"U\u00e7ar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najla","family":"Albader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Qattan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda A.","family":"BinEssa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru M\u0131s\u0131rl\u0131","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjing","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali S.","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6999-0191","authenticated-orcid":false,"given":"Yufei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"4335_CR1","doi-asserted-by":"publisher","unstructured":"Beck-Nielsen SS, Brock-Jacobsen B, Gram J, Brixen K, Jensen TK. Incidence and prevalence of nutritional and hereditary rickets in southern Denmark. Eur J Endocrinol. 2009;160(3):491\u2013497. https:\/\/doi.org\/10.1530\/EJE-1508-0818. Epub 2008 Dec 1518.","DOI":"10.1530\/EJE-1508-0818"},{"issue":"Suppl 2","key":"4335_CR2","first-page":"88","volume":"9","author":"S Acar","year":"2017","unstructured":"Acar S, Demir K, Shi Y. Genetic Causes of Rickets. J Clin Res Pediatr Endocrinol. 2017;9(Suppl 2):88\u2013105.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"4335_CR3","doi-asserted-by":"crossref","unstructured":"Haffner D, Emma F, Eastwood DM, Duplan MB, Bacchetta J, Schnabel D, Wicart P, Bockenhauer D, Santos F, Levtchenko E, Harvengt P, Kirchhoff M, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenicky P, Rejnmark L, Linglart A. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol. 2019;15(7):435\u2013455. https:\/\/doi.org\/10.1038\/s41581-41019-40152-41585.","DOI":"10.1038\/s41581-019-0152-5"},{"issue":"3","key":"4335_CR4","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/81664","volume":"26","author":"Autosomal dominant hypophosphataemic","year":"2000","unstructured":"Autosomal dominant hypophosphataemic. rickets is associated with mutations in FGF23. Nat Genet. 2000;26(3):345\u20138.","journal-title":"Nat Genet"},{"issue":"11","key":"4335_CR5","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/ng1868","volume":"38","author":"B Lorenz-Depiereux","year":"2006","unstructured":"Lorenz-Depiereux B, Bastepe M, Benet-Pages A, Amyere M, Wagenstaller J, Muller-Barth U, Badenhoop K, Kaiser SM, Rittmaster RS, Shlossberg AH, Olivares JL, Loris C, Ramos FJ, Glorieux F, Vikkula M, Juppner H, Strom TM. DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat Genet. 2006;38(11):1248\u201350. Epub 2006 Oct 1248.","journal-title":"Nat Genet"},{"issue":"2","key":"4335_CR6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ajhg.2010.01.010","volume":"86","author":"V Levy-Litan","year":"2010","unstructured":"Levy-Litan V, Hershkovitz E, Avizov L, Leventhal N, Bercovich D, Chalifa-Caspi V, Manor E, Buriakovsky S, Hadad Y, Goding J, Parvari R. Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene. Am J Hum Genet. 2010;86(2):273\u20138.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"4335_CR7","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1006\/geno.1995.9960","volume":"29","author":"SE Fisher","year":"1995","unstructured":"Fisher SE, van Bakel I, Lloyd SE, Pearce SH, Thakker RV, Craig IW. Cloning and characterization of CLCN5, the human kidney chloride channel gene implicated in Dent disease (an X-linked hereditary nephrolithiasis). Genomics. 1995;29(3):598\u2013606.","journal-title":"Genomics"},{"key":"4335_CR8","unstructured":"Lieske JC, Milliner DS, Beara-Lasic L, Harris P, Hopp K, Cogal A, Mattison K. Dent Disease."},{"issue":"2","key":"4335_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1086\/499409","volume":"78","author":"C Bergwitz","year":"2006","unstructured":"Bergwitz C, Roslin NM, Tieder M, Loredo-Osti JC, Bastepe M, Abu-Zahra H, Frappier D, Burkett K, Carpenter TO, Anderson D, Garabedian M, Sermet I, Fujiwara TM, Morgan K, Tenenhouse HS, Juppner H. SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. Am J Hum Genet. 2006;78(2):179\u201392. Epub 2005 Dec 2009.","journal-title":"Am J Hum Genet"},{"issue":"13","key":"4335_CR10","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1056\/NEJMoa020028","volume":"347","author":"D Prie","year":"2002","unstructured":"Prie D, Huart V, Bakouh N, Planelles G, Dellis O, Gerard B, Hulin P, Benque-Blanchet F, Silve C, Grandchamp B, Friedlander G. Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. N Engl J Med. 2002;347(13):983\u201391.","journal-title":"N Engl J Med"},{"issue":"11","key":"4335_CR11","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJMoa0802836","volume":"359","author":"Z Karim","year":"2008","unstructured":"Karim Z, G\u00e9rard B, Bakouh N, Alili R, Leroy C, Beck L, Silve C, Planelles G, Urena-Torres P, Grandchamp B, Friedlander G, Pri\u00e9 D. NHERF1 mutations and responsiveness of renal parathyroid hormone. N Engl J Med. 2008;359(11):1128\u201335.","journal-title":"N Engl J Med"},{"issue":"2","key":"4335_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s40610-019-0118-1","volume":"5","author":"TJ Weber","year":"2019","unstructured":"Weber TJ, Quarles LD. Molecular Control of Phosphorus Homeostasis and Precision Treatment of Hypophosphatemic Disorders. Curr Mol biology Rep. 2019;5(2):75\u201385.","journal-title":"Curr Mol biology Rep"},{"issue":"5","key":"4335_CR13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/ki.2011.146","volume":"80","author":"PA Torres","year":"2011","unstructured":"Torres PA, De Brauwere DP. Three feedback loops precisely regulating serum phosphate concentration. Kidney Int. 2011;80(5):443\u20135.","journal-title":"Kidney Int"},{"key":"4335_CR14","doi-asserted-by":"crossref","unstructured":"Beck-Nielsen SS, Brixen K, Gram J, Brusgaard K. Mutational analysis of PHEX, FGF23, DMP1, SLC34A3 and CLCN5 in patients with hypophosphatemic rickets. J Hum Genet. 2012;57(7):453\u2013458. Epub 2012 Jun 1014 https:\/\/doi.org\/10.1038\/jhg.2012.1056.","DOI":"10.1038\/jhg.2012.56"},{"issue":"3","key":"4335_CR15","doi-asserted-by":"publisher","first-page":"e0193388","DOI":"10.1371\/journal.pone.0193388","volume":"13","author":"S Acar","year":"2018","unstructured":"Acar S, BinEssa HA, Demir K, Al-Rijjal RA, Zou M, \u00c7atli G, An\u0131k A, Al-Enezi AF, \u00d6z\u0131\u015f\u0131k S, Al-Faham MSA, Abac\u0131 A, D\u00fcndar B, Kattan WE, Alsagob M, Kavuk\u00e7u S, Tamimi HE, Meyer BF, B\u00f6ber E, Shi Y. Clinical and genetic characteristics of 15 families with hereditary hypophosphatemia: Novel Mutations in PHEX and SLC34A3. PLoS ONE. 2018;13(3):e0193388.","journal-title":"PLoS ONE"},{"key":"4335_CR16","doi-asserted-by":"crossref","unstructured":"Cebeci AN, Zou M, BinEssa HA, Alzahrani AS, Al-Rijjal RA, Al-Enezi AF, Al-Mohanna FA, Cavalier E, Meyer BF, Shi Y. Mutation of SGK3, a novel regulator of renal phosphate transport, causes autosomal dominant hypophosphatemic rickets. J Clin Endocrinol Metab. 2020;105(6).","DOI":"10.1210\/clinem\/dgz260"},{"issue":"1","key":"4335_CR17","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.bone.2012.10.012","volume":"52","author":"E Durmaz","year":"2013","unstructured":"Durmaz E, Zou M, Al-Rijjal RA, Baitei EY, Hammami S, Bircan I, Ak\u00e7urin S, Meyer B, Shi Y. Novel and de novo PHEX mutations in patients with hypophosphatemic rickets. Bone. 2013;52(1):286\u201391.","journal-title":"Bone"},{"issue":"1","key":"4335_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/cen.13347","volume":"87","author":"A Guven","year":"2017","unstructured":"Guven A, Al-Rijjal RA, BinEssa HA, Dogan D, Kor Y, Zou M, Kaya N, Alenezi AF, Hancili S, Tar\u0131m \u00d6, Baitei EY, Kattan WE, Meyer BF, Shi Y. Mutational analysis of PHEX, FGF23 and CLCN5 in patients with hypophosphataemic rickets. Clin Endocrinol. 2017;87(1):103\u201312.","journal-title":"Clin Endocrinol"},{"key":"4335_CR19","doi-asserted-by":"publisher","unstructured":"Zou M, Alzahrani AS, Al-Odaib A, Alqahtani MA, Babiker O, Al-Rijjal RA, BinEssa HA, Kattan WE, Al-Enezi AF, Al Qarni A, Al-Faham MSA, Baitei EY, Alsagheir A, Meyer BF, Shi Y. Molecular analysis of congenital hypothyroidism in Saudi Arabia: SLC26A7 mutation is a novel defect in thyroid dyshormonogenesis. J Clin Endocrinol Metab. 2018;103(5):1889\u20131898. https:\/\/doi.org\/10.1210\/jc.2017-02202.","DOI":"10.1210\/jc.2017-02202"},{"issue":"W1","key":"4335_CR20","doi-asserted-by":"publisher","first-page":"W490","DOI":"10.1093\/nar\/gkx376","volume":"45","author":"L Kreft","year":"2017","unstructured":"Kreft L, Soete A, Hulpiau P, Botzki A, Saeys Y, De Bleser P. ConTra v3: a tool to identify transcription factor binding sites across species, update 2017. Nucleic Acids Res. 2017;45(W1):W490\u20134.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"4335_CR21","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/ng844","volume":"30","author":"S Hopyan","year":"2002","unstructured":"Hopyan S, Gokgoz N, Poon R, Gensure RC, Yu C, Cole WG, Bell RS, J\u00fcppner H, Andrulis IL, Wunder JS, Alman BA. A mutant PTH\/PTHrP type I receptor in enchondromatosis. Nat Genet. 2002;30(3):306\u201310.","journal-title":"Nat Genet"},{"issue":"1","key":"4335_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/ki.2011.67","volume":"80","author":"M Bhandaru","year":"2011","unstructured":"Bhandaru M, Kempe DS, Rotte A, Capuano P, Pathare G, Sopjani M, Alesutan I, Tyan L, Huang DY, Siraskar B, Judenhofer MS, Stange G, Pichler BJ, Biber J, Quintanilla-Martinez L, Wagner CA, Pearce D, F\u00f6ller M, Lang F. Decreased bone density and increased phosphaturia in gene-targeted mice lacking functional serum- and glucocorticoid-inducible kinase 3. Kidney Int. 2011;80(1):61\u20137.","journal-title":"Kidney Int"},{"issue":"1","key":"4335_CR23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1210\/me.2010-0294","volume":"25","author":"Y Wang","year":"2011","unstructured":"Wang Y, Zhou D, Phung S, Masri S, Smith D, Chen S. SGK3 is an estrogen-inducible kinase promoting estrogen-mediated survival of breast cancer cells. Mol Endocrinol (Baltimore Md). 2011;25(1):72\u201382.","journal-title":"Mol Endocrinol (Baltimore Md)"},{"issue":"6","key":"4335_CR24","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1210\/me.2013-1339","volume":"28","author":"Y Wang","year":"2014","unstructured":"Wang Y, Zhou D, Chen S. SGK3 is an androgen-inducible kinase promoting prostate cancer cell proliferation through activation of p70 S6 kinase and up-regulation of cyclin D1. Mol Endocrinol (Baltimore Md). 2014;28(6):935\u201348.","journal-title":"Mol Endocrinol (Baltimore Md)"},{"issue":"4","key":"4335_CR25","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1210\/me.2006-0113","volume":"21","author":"SM Eacker","year":"2007","unstructured":"Eacker SM, Shima JE, Connolly CM, Sharma M, Holdcraft RW, Griswold MD, Braun RE. Transcriptional profiling of androgen receptor (AR) mutants suggests instructive and permissive roles of AR signaling in germ cell development. Mol Endocrinol (Baltimore Md). 2007;21(4):895\u2013907.","journal-title":"Mol Endocrinol (Baltimore Md)"},{"issue":"12","key":"4335_CR26","first-page":"2229","volume":"6","author":"PJ Roche","year":"1992","unstructured":"Roche PJ, Hoare SA, Parker MG. A consensus DNA-binding site for the androgen receptor. Mol Endocrinol (Baltimore Md). 1992;6(12):2229\u201335.","journal-title":"Mol Endocrinol (Baltimore Md)"},{"issue":"1","key":"4335_CR27","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1096\/fj.15-278184","volume":"30","author":"Y Fan","year":"2016","unstructured":"Fan Y, Bi R, Densmore MJ, Sato T, Kobayashi T, Yuan Q, Zhou X, Erben RG, Lanske B. Parathyroid hormone 1 receptor is essential to induce FGF23 production and maintain systemic mineral ion homeostasis. FASEB journal: official publication Federation Am Soc Experimental Biology. 2016;30(1):428\u201340.","journal-title":"FASEB journal: official publication Federation Am Soc Experimental Biology"},{"issue":"1","key":"4335_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1210\/jc.2008-0220","volume":"94","author":"WW Brown","year":"2009","unstructured":"Brown WW, J\u00fcppner H, Langman CB, Price H, Farrow EG, White KE, McCormick KL. Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen\u2019s metaphyseal chondrodysplasia. J Clin Endocrinol Metab. 2009;94(1):17\u201320.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5207","key":"4335_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1126\/science.7701349","volume":"268","author":"E Schipani","year":"1995","unstructured":"Schipani E, Kruse K, J\u00fcppner H. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Sci (New York NY). 1995;268(5207):98\u2013100.","journal-title":"Sci (New York NY)"},{"issue":"10","key":"4335_CR30","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1056\/NEJM199609053351004","volume":"335","author":"E Schipani","year":"1996","unstructured":"Schipani E, Langman CB, Parfitt AM, Jensen GS, Kikuchi S, Kooh SW, Cole WG, J\u00fcppner H. Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen\u2019s metaphyseal chondrodysplasia. N Engl J Med. 1996;335(10):708\u201314.","journal-title":"N Engl J Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04335-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04335-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04335-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:31:09Z","timestamp":1788172269000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04335-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4335"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04335-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Review Board of King Faisal Specialist Hospital and Research Center and conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from the patient and participating family members. For participants under 18 years of age, written informed consent was obtained from their parents or legal guardians.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The manuscript is approved for publication by the Institutional Review Board.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have nothing to disclose.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"310"}}